VBNG TV

Every medicine comes with a recipe, and the recipe is far longer than most people would guess. Before a drug reaches a pharmacy shelf, its maker has to record exactly how it is produced, how each batch is tested and what counts as acceptable quality. The industry calls this work Chemistry, Manufacturing and Controls, or CMC, and much of it still runs on manual, document-based processes with little standardization. That is the problem a new industry group wants to fix. Rockwell Automation, Inc.

Every day, somewhere in the world, an airline locks in the price of jet fuel, a grain exporter fixes what it will earn on a shipment months away, and a pension fund protects itself against a slide in stock prices. They do it with derivatives, contracts whose value follows something else, such as oil, wheat or a stock index. For decades the busiest markets for these contracts have been in the United States. What has been changing is who shows up to use them.

Budgets for artificial intelligence keep climbing, yet the people who approve them sound less sure that the technology alone will grow their companies. A survey released on today puts numbers on that doubt. It asked 1,330 board members and senior executives around the world what worries them and where they expect growth to come from, and the answers point to a lot of unfinished work inside their own organizations.

Most of what a business spends never arrives as one dramatic bill. It leaks out in small amounts: an extra employee kept on standby just in case, a delivery truck that takes the long way, a spreadsheet that two departments update separately and never quite reconcile. Software earns its keep by finding those leaks. It does not make the work disappear. It makes the work visible, so managers can see where time, fuel, and wages are going and decide what to change.

Finding something to watch used to mean flipping through a channel guide. Today it often means opening four or five apps, remembering which one carries which show, and hoping the game you want has not moved to a service you do not pay for. Two announcements today show how the television business is responding. One company built a guide that sits on top of everyone else’s programming. Another placed its specialty services inside a larger distributor’s lineup.

When a company has spare cash, it has a short list of things it can do with it. It can invest in the business, pay down debt, hand money to shareholders as a dividend, or buy its own shares back from the market. That last option, known as a share buyback or repurchase, tends to draw the most attention, partly because of what it implies about how the people running the company see its value. The mechanics are simple.

From Hollywood Blockbusters to a Story That Moves the Heart: Filmmaker Laurence Walsh on The Oksana Show Lights, camera, inspiration. This week on The Oksana Show, host Oksana Kolesnikova sits down with writer, producer and director Laurence Walsh, a storyteller whose career runs from the sets of major Hollywood films to the writers’ rooms of hit network TV.

PLEASE REVIEW THE DISCLAIMER ON THE BOTTOM OF THE PAGE Key Takeaways This Month This review covers the last 30 days. Over this period, small-cap technology moved from the center of the equity trade back to the sidelines. From the September 4th close through October 5th, the Russell 2000 fell 4.3% to 2,847.14, while the Nasdaq 100 gained 5.2% to 31,076.44 and the S&P 500 added 0.7% to 7,773.95.

Analyst Certification Each authoring analyst of Atrium Research on this report certifies that (i) the recommendations and opinions expressed in this research accurately reflect the authoring analyst’s personal, independent and objective views about any and all of the designated securities discussed (ii) no part of the authoring analyst’s compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in the research, (iii) to the best of...

Analyst Certification Each authoring analyst of Atrium Research on this report certifies that (i) the recommendations and opinions expressed in this research accurately reflect the authoring analyst’s personal, independent and objective views about any and all of the designated securities discussed (ii) no part of the authoring analyst’s compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in the research, (iii) to the best of...